Day: June 20, 2020

Glenmark's Favipiravir, marketed as 'Fabiflu' | From a presentation submitted by Glenmark to the BSE India exchange
News

Glenmark launches drug Fabiflu in India after DCGI approval, for treatment of mild to moderate COVID-19 patients, MRP at Rs 103 per tablet

— June 20, 2020 0 comment
YD NEWS | Glenmark launches COVID drug FabiFlu Mumbai: Drug firm Glenmark Pharmaceuticals on Saturday said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients... Read more »